Laurence Barker joined SV in 2016, bringing over 20 years of venture, biotech, and pharma experience. He previously led investment management at GSK and worked in business development at Syntaxin and MorphoSys.
What Laurence can write
Career
- Syntaxin · business development
- MorphoSys · business development
- GSK · Head of Investment Management in Worldwide Business Development
- Dementia Discovery Fund (DDF)
- SV2016
- Dementia Discovery Fund
- SV Health Investors · PartnerNow
Investments named in public bios
Focus
Education
Also at SV Health Investors
Partners like Laurence
At firms with a similar stage, sector and check size.
Alert me when SV Health Investors is active
One email when Laurence's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Laurence Barker?
Laurence Barker joined SV in 2016, bringing over 20 years of venture, biotech, and pharma experience. He previously led investment management at GSK and worked in business development at Syntaxin and MorphoSys.
How much does Laurence Barker invest?
SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.
How do I pitch Laurence Barker?
A warm intro from a founder SV Health Investors backed works best.
What did Laurence Barker do before SV Health Investors?
business development at Syntaxin; business development at MorphoSys; Head of Investment Management in Worldwide Business Development at GSK; Dementia Discovery Fund (DDF); SV; Dementia Discovery Fund.
Last updated 2026-10-15. Is this you? Ask for a correction.